Josh Peterson
Last active: 5/19/2014

Josh Peterson M.D. - Publications

  1. Using systems approaches to address challenges for clinical implementation of pharmacogenomics. Karnes JH, Van Driest S, Bowton EA, Weeke PE, Mosley JD, Peterson JF, Denny JC, Roden DM (2014) Wiley Interdiscip Rev Syst Biol Med 6(2): 125-35
    › Primary publication · 24319008 (PubMed) · PMC3944797 (PubMed Central)
  2. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Van Driest SL, Shi Y, Bowton EA, Schildcrout JS, Peterson JF, Pulley J, Denny JC, Roden DM (2014) Clin Pharmacol Ther 95(4): 423-31
    › Primary publication · 24253661 (PubMed) · PMC3961508 (PubMed Central)
  3. Biobanks and electronic medical records: enabling cost-effective research. Bowton E, Field JR, Wang S, Schildcrout JS, Van Driest SL, Delaney JT, Cowan J, Weeke P, Mosley JD, Wells QS, Karnes JH, Shaffer C, Peterson JF, Denny JC, Roden DM, Pulley JM (2014) Sci Transl Med 6(234): 234cm3
    › Primary publication · 24786321 (PubMed) · PMC4226414 (PubMed Central)
  4. Use of multiple imputation method to improve estimation of missing baseline serum creatinine in acute kidney injury research. Siew ED, Peterson JF, Eden SK, Moons KG, Ikizler TA, Matheny ME (2013) Clin J Am Soc Nephrol 8(1): 10-8
    › Primary publication · 23037980 (PubMed) · PMC3531649 (PubMed Central)
  5. Electronic health record design and implementation for pharmacogenomics: a local perspective. Peterson JF, Bowton E, Field JR, Beller M, Mitchell J, Schildcrout J, Gregg W, Johnson K, Jirjis JN, Roden DM, Pulley JM, Denny JC (2013) Genet Med 15(10): 833-41
    › Primary publication · 24009000 (PubMed) · PMC3925979 (PubMed Central)
  6. Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study. Janz DR, Bastarache JA, Peterson JF, Sills G, Wickersham N, May AK, Roberts LJ, Ware LB (2013) Crit Care Med 41(3): 784-90
    › Primary publication · 23314583 (PubMed) · PMC3578977 (PubMed Central)
  7. Adverse drug events during AKI and its recovery. Cox ZL, McCoy AB, Matheny ME, Bhave G, Peterson NB, Siew ED, Lewis J, Danciu I, Bian A, Shintani A, Ikizler TA, Neal EB, Peterson JF (2013) Clin J Am Soc Nephrol 8(7): 1070-8
    › Primary publication · 23539228 (PubMed) · PMC3700703 (PubMed Central)
  8. Real-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury: a randomized, controlled trial. McCoy AB, Cox ZL, Neal EB, Waitman LR, Peterson NB, Bhave G, Siew ED, Danciu I, Lewis JB, Peterson JF (2012) Appl Clin Inform 3(2): 221-238
    › Primary publication · 22719796 (PubMed) · PMC3377180 (PubMed Central)
  9. Outpatient nephrology referral rates after acute kidney injury. Siew ED, Peterson JF, Eden SK, Hung AM, Speroff T, Ikizler TA, Matheny ME (2012) J Am Soc Nephrol 23(2): 305-12
    › Primary publication · 22158435 (PubMed) · PMC3269178 (PubMed Central)
  10. Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. Schildcrout JS, Denny JC, Bowton E, Gregg W, Pulley JM, Basford MA, Cowan JD, Xu H, Ramirez AH, Crawford DC, Ritchie MD, Peterson JF, Masys DR, Wilke RA, Roden DM (2012) Clin Pharmacol Ther 92(2): 235-42
    › Primary publication · 22739144 (PubMed) · PMC3785311 (PubMed Central)